Resflor Gold (florfenicol and flunixin meglumine) is a simple bovine respiratory disease (BRD) treatment strategy. It involves a combination of two therapies in one dose the powerful antibiotic florfenicol to kill or inhibit the disease-causing bacteria Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis and, the fast-acting non-steroidal anti-inflammatory drug (NSAID) flunixin meglumine to reduce BRD-associated fever. RESFLOR GOLD provides a two-pronged attack against BRD, targeting the bacterial infection and its associated fever. The fast-acting florfenicol reformulation achieves high blood levels quickly in combination with a NSAID to reduce fever and provide a more visible recovery from the disease within six hours of initial dosage. RESFLOR GOLD should be administered once by subcutaneous injection at a dose rate of 40 mg florfenicol/kg body weight and 2.2 mg flunixin/kg body weight (6 mL/100 lb). Do not administer more than 10 mL at each site.
The injection should be given only in the neck. Injection sites other than the neck have not been evaluated. RESIDUE WARNINGS: Animals intended for human consumption must not be slaughtered within 38 days of reatment. Do not use in female dairy cattle 20 months of ge or older. Use of florfenicol in this class of cattle may cause milk residues. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.
| SKU | resflor_gold_cp |
|---|---|
| Manufacturer | Merck Animal Health |
| ORMD | No |
| Hazardous | No |
| Ailment | BRD, Mannheimia, Mycoplasma, Pasteurella |
| Product Label | Click Here |
| SDS | Click Here |
